Grant of Share Options

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces the grant of unapproved share options over ordinary shares of 1 penny each to directors as follows.

Lisa Baderoon     3,000,000 share options (exercise price: 2.24p)

Laurence Reilly   2,000,000 share options (exercise price: 2.24p)

Share Option Period: All Share Options are valid for 10 years from the date of issue and will vest three years from the date of issue.

For full announcement download here